|
Volumn 22, Issue 4, 2002, Pages 388-392
|
Effects of reboxetine on anxiety, agitation, and insomnia: Results of a pooled evaluation of randomized clinical trials
a b c,d |
Author keywords
[No Author keywords available]
|
Indexed keywords
PLACEBO;
REBOXETINE;
ADULT;
AGED;
AGITATION;
ANXIETY;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DEPRESSION;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DOSE RESPONSE;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
FEMALE;
HUMAN;
INSOMNIA;
MAJOR CLINICAL STUDY;
MALE;
PRIORITY JOURNAL;
PSYCHOPHARMACOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
TITRIMETRY;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADULT;
ANTIDEPRESSIVE AGENTS;
ANXIETY;
CONFIDENCE INTERVALS;
DEPRESSIVE DISORDER, MAJOR;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MORPHOLINES;
PSYCHOMOTOR AGITATION;
RANDOMIZED CONTROLLED TRIALS;
SLEEP INITIATION AND MAINTENANCE DISORDERS;
|
EID: 0036327422
PISSN: 02710749
EISSN: None
Source Type: Journal
DOI: 10.1097/00004714-200208000-00009 Document Type: Article |
Times cited : (35)
|
References (15)
|